Sign In
Buy AKBA
$0.97
+0.0333 (+3.56%)
At Close: Jun 03, 2026
Akebia Therapeutics to Present at the H.C. Wainwright Kidney Conference
07:45am, Wednesday, 19'th Jul 2023
CAMBRIDGE, Mass. , July 19, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today
Best Stocks For Beginners with Little Money: How To Trade Penny Stocks
12:16pm, Monday, 10'th Jul 2023
There are so many new traders and investors entering the stock market today. But if you're brand new, you might not have a lot of money to invest or don't want to risk a whole lot while you're learnin
Pocket Change, Big Gains: 3 Penny Stocks Ready to Boom
06:07am, Thursday, 06'th Jul 2023
Investors seeking high-growth opportunities often turn their attention to penny stocks, which may have the potential to deliver substantial returns. The three potential high return penny stocks listed
Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?
10:58am, Monday, 19'th Jun 2023
Here is how Akebia Therapeutics (AKBA) and Haemonetics (HAE) have performed compared to their sector so far this year.
3 Hot Penny Stocks To Watch Before Next Week
02:19pm, Wednesday, 07'th Jun 2023
Penny stocks typically trade for less than $5 and generally belong to small companies often overlooked by mainstream investors. Yet, for those willing to navigate the inherent risks, these cheap stock
All You Need to Know About Akebia Therapeutics (AKBA) Rating Upgrade to Buy
01:09pm, Friday, 02'nd Jun 2023
Akebia Therapeutics (AKBA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Are Medical Stocks Lagging Akebia Therapeutics (AKBA) This Year?
10:53am, Friday, 02'nd Jun 2023
Here is how Akebia Therapeutics (AKBA) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
Akebia Therapeutics to Present at Jefferies Healthcare Conference
08:30am, Friday, 02'nd Jun 2023
CAMBRIDGE, Mass. , June 2, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today
4 Hot Penny Stocks To Watch This Week
11:20am, Thursday, 01'st Jun 2023
In the world of investment, penny stocks hold a unique position. Often priced at $5 per share or less, these are typically shares of small-cap companies that trade at relatively low prices.
Akebia Therapeutics: Buy This Undervalued Stock At Just 77% Of Revenue
08:11am, Monday, 29'th May 2023
Akebia Therapeutics Inc. is rated a Strong Buy due to its overly discounted revenue and strong prospects in the large Chronic Kidney Disease market. The company's valuation should be at least $716 mil
Why Shares of Akebia Therapeutics Were Up Tuesday
11:27am, Tuesday, 23'rd May 2023
Akebia gained approval for Vafseo, its anemia therapy for chronic kidney disease patients, in Great Britain. The company is awaiting word on its appeal to the FDA to get approval for the therapy in th
Akebia Therapeutics, Inc. (AKBA) Q1 2023 Earnings Call Transcript
10:25am, Monday, 08'th May 2023
Akebia Therapeutics, Inc. (NASDAQ:AKBA ) Q1 2023 Earnings Conference Call May 8, 2023 8:30 AM ET Company Participants Mercedes Carrasco - Senior Director of Investor and Corporate Communications John
Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates
09:54am, Monday, 08'th May 2023
Akebia Therapeutics (AKBA) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.35 per share a year ago.
4 Top Penny Stocks To Buy According To Analysts, Targets Up To 695%
11:12am, Thursday, 27'th Apr 2023
Analysts say these could be penny stocks to buy. Do you agree with their outlook?
Penny Stocks To Buy? 4 To Watch Now After Big News This Week
12:52pm, Monday, 03'rd Apr 2023
Penny stocks to watch with news this week. Are they a buy now or should you avoid them entirely?
